Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Co-crystallization of human inositol monophosphatase with the lithium mimetic L-690,330.

Kraft L, Roe SM, Gill R, Atack JR.

Acta Crystallogr D Struct Biol. 2018 Oct 1;74(Pt 10):973-978. doi: 10.1107/S2059798318010380. Epub 2018 Oct 2.

PMID:
30289407
2.

High-resolution structure of myo-inositol monophosphatase, the putative target of lithium therapy.

Gill R, Mohammed F, Badyal R, Coates L, Erskine P, Thompson D, Cooper J, Gore M, Wood S.

Acta Crystallogr D Biol Crystallogr. 2005 May;61(Pt 5):545-55. Epub 2005 Apr 20.

PMID:
15858264
3.

Inositol monophosphatase inhibitors--lithium mimetics?

Atack JR.

Med Res Rev. 1997 Mar;17(2):215-24. Review.

PMID:
9057165
4.

Effects of L-690,488, a prodrug of the bisphosphonate inositol monophosphatase inhibitor L-690,330, on phosphatidylinositol cycle markers.

Atack JR, Prior AM, Fletcher SR, Quirk K, McKernan R, Ragan CI.

J Pharmacol Exp Ther. 1994 Jul;270(1):70-6.

PMID:
8035344
5.

Inositol monophosphatase, the putative therapeutic target for lithium.

Atack JR.

Brain Res Brain Res Rev. 1996 Aug;22(2):183-90. Review.

PMID:
8883919
6.

Calbindin D28k and S100B have a similar interaction site with the lithium-inhibitable enzyme inositol monophosphatase-1: a new drug target site.

Agam G, Almog O.

J Med Chem. 2015 Feb 26;58(4):2042-4. doi: 10.1021/jm5019324. Epub 2015 Feb 16.

PMID:
25665147
7.

Inositol monophosphatase--a putative target for Li+ in the treatment of bipolar disorder.

Atack JR, Broughton HB, Pollack SJ.

Trends Neurosci. 1995 Aug;18(8):343-9. Review.

PMID:
7482796
8.

Structure and mechanism of inositol monophosphatase.

Atack JR, Broughton HB, Pollack SJ.

FEBS Lett. 1995 Mar 13;361(1):1-7. Review.

9.

Determination of the lithium binding site in inositol monophosphatase, the putative target for lithium therapy, by magic-angle-spinning solid-state NMR.

Haimovich A, Eliav U, Goldbourt A.

J Am Chem Soc. 2012 Mar 28;134(12):5647-51. doi: 10.1021/ja211794x. Epub 2012 Mar 15.

PMID:
22384802
10.

Myo-inositol monophosphatase: diverse effects of lithium, carbamazepine, and valproate.

Vadnal R, Parthasarathy R.

Neuropsychopharmacology. 1995 Jul;12(4):277-85.

11.

The inositol monophosphatase inhibitor L-690,330 affects pilocarpine-behavior and the forced swim test.

Shtein L, Toker L, Bersudsky Y, Belmaker RH, Agam G.

Psychopharmacology (Berl). 2013 Jun;227(3):503-8. doi: 10.1007/s00213-013-2969-0. Epub 2013 Jan 24.

PMID:
23344554
12.

Structural elucidation of the binding site and mode of inhibition of Li(+) and Mg(2+) in inositol monophosphatase.

Dutta A, Bhattacharyya S, Dutta D, Das AK.

FEBS J. 2014 Dec;281(23):5309-24. doi: 10.1111/febs.13070. Epub 2014 Oct 27.

13.

In vitro and in vivo inhibition of inositol monophosphatase by the bisphosphonate L-690,330.

Atack JR, Cook SM, Watt AP, Fletcher SR, Ragan CI.

J Neurochem. 1993 Feb;60(2):652-8.

PMID:
8380439
14.

Inhibitors of inositol monophosphatase.

Fauroux CM, Freeman S.

J Enzyme Inhib. 1999;14(2):97-108. Review.

PMID:
10445037
15.
16.

Cloning, expression, purification, crystallization and X-ray analysis of inositol monophosphatase from Mus musculus and Homo sapiens.

Singh N, Halliday AC, Knight M, Lack NA, Lowe E, Churchill GC.

Acta Crystallogr Sect F Struct Biol Cryst Commun. 2012 Oct 1;68(Pt 10):1149-52. doi: 10.1107/S1744309112035191. Epub 2012 Sep 22.

17.
18.

Increased inositol-monophosphatase activity by lithium treatment in bipolar patients.

Kaya N, Resmi H, Ozerdem A, Guner G, Tunca Z.

Prog Neuropsychopharmacol Biol Psychiatry. 2004 May;28(3):521-7.

PMID:
15093960
19.

Spatial expression patterns and biochemical properties distinguish a second myo-inositol monophosphatase IMPA2 from IMPA1.

Ohnishi T, Ohba H, Seo KC, Im J, Sato Y, Iwayama Y, Furuichi T, Chung SK, Yoshikawa T.

J Biol Chem. 2007 Jan 5;282(1):637-46. Epub 2006 Oct 26.

20.

Regional changes in rat brain inositol monophosphatase 1 (IMPase 1) activity with chronic lithium treatment.

Parthasarathy LK, Seelan RS, Wilson MA, Vadnal RE, Parthasarathy RN.

Prog Neuropsychopharmacol Biol Psychiatry. 2003 Feb;27(1):55-60.

PMID:
12551726

Supplemental Content

Support Center